ArrowMark Colorado Holdings LLC - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 126 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
ArrowMark Colorado Holdings LLC ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$13,207,332
-4.8%
760,353
-22.8%
0.16%
+5.9%
Q2 2023$13,871,560
+45.4%
985,196
+11.1%
0.15%
+40.7%
Q1 2023$9,542,721
-11.2%
886,870
+23.7%
0.11%
-15.6%
Q4 2022$10,743,222
-9.8%
717,171
-22.7%
0.13%
-12.3%
Q3 2022$11,917,000
+6.8%
928,094
-19.4%
0.15%
+14.1%
Q2 2022$11,155,000
-15.0%
1,151,137
-12.9%
0.13%
+11.3%
Q1 2022$13,131,000
-12.4%
1,320,977
+3.8%
0.12%
-4.2%
Q4 2021$14,984,000
+6.5%
1,273,049
+3.1%
0.12%
+9.1%
Q3 2021$14,063,000
+17.4%
1,234,650
+43.6%
0.11%
+22.2%
Q2 2021$11,978,000
-25.7%
859,874
-1.2%
0.09%
-25.0%
Q1 2021$16,112,000
-21.1%
870,422
-24.7%
0.12%
-24.1%
Q4 2020$20,432,000
+15.0%
1,156,338
-0.3%
0.16%
-6.5%
Q3 2020$17,760,000
-10.0%
1,159,301
-9.0%
0.17%
-34.7%
Q1 2020$19,728,000
-21.9%
1,274,424
-44.2%
0.26%
+15.1%
Q4 2019$25,257,000
+45.1%
2,283,661
+11.6%
0.22%
+29.3%
Q3 2019$17,407,000
-27.9%
2,045,508
+14.7%
0.17%
-25.0%
Q2 2019$24,154,000
-16.9%
1,783,884
+10.8%
0.23%
-15.3%
Q1 2019$29,080,000
-16.3%
1,610,181
+30.2%
0.27%
-24.9%
Q4 2018$34,741,000
+31.1%
1,236,770
+3.7%
0.36%
+64.4%
Q3 2018$26,494,000
+915.9%
1,192,424
+693.2%
0.22%
+825.0%
Q2 2018$2,608,000150,3310.02%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q4 2022
NameSharesValueWeighting ↓
Spearhead Capital Advisors, LLC 202,580$2,601,0002.82%
Lion Point Capital, LP 480,000$5,140,0001.13%
HHLR ADVISORS, LTD. 2,920,023$37,493,0000.99%
TANG CAPITAL MANAGEMENT LLC 600,000$7,704,0000.94%
Rubric Capital Management LP 1,446,107$18,568,0000.94%
AlphaCentric Advisors LLC 43,000$552,0000.57%
RICE HALL JAMES & ASSOCIATES, LLC 749,933$9,629,0000.56%
Parkman Healthcare Partners LLC 126,192$1,620,0000.46%
Birchview Capital, LP 30,000$385,0000.27%
Baker Brothers Advisors 2,799,577$35,947,0000.24%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders